AAAAAA
Results:
1-11
|
Results: 11
Authors:
Schippers, EF
Hugen, PWH
den Hartigh, J
Burger, DM
Hoetelmans, RMW
Visser, LG
Kroon, FP
Citation: Ef. Schippers et al., No drug-drug interaction between nelfinavir or indinavir and mefloquine inHIV-1-infected patients, AIDS, 14(17), 2000, pp. 2794-2795
Authors:
Kroon, FP
van Dissel, JT
Ravensbergen, E
Nibbering, PH
van Furth, R
Citation: Fp. Kroon et al., Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults, VACCINE, 19(7-8), 2000, pp. 886-894
Antibody response after influenza vaccination in HIV-infected individuals:a consecutive 3-year study
Authors:
Kroon, FP
van Dissel, JT
de Jong, JC
Zwinderman, L
van Furth, R
Citation: Fp. Kroon et al., Antibody response after influenza vaccination in HIV-infected individuals:a consecutive 3-year study, VACCINE, 18(26), 2000, pp. 3040-3049
Authors:
Verhagen, CE
de Boer, T
Smits, HH
Verreck, FAW
Wierenga, EA
Kurimoto, M
Lammas, DA
Kumararatne, DS
Sanal, O
Kroon, FP
van Dissel, JT
Sinigaglia, F
Ottenhoff, THM
Citation: Ce. Verhagen et al., Residual type 1 immunity in patients genetically deficient for interleukin12 receptor beta 1 (IL-12R beta 1): Evidence for an IL-12R beta 1-independent pathway of IL-12 responsiveness in human T cells, J EXP MED, 192(4), 2000, pp. 517-528
Authors:
Kroon, FP
van Tol, MJD
Jol-van der Zijde, CM
van Furth, R
van Dissel, JT
Citation: Fp. Kroon et al., Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoid, CL DIAG LAB, 6(3), 1999, pp. 352-355
Authors:
Stuart, JWTC
Schuurman, R
Burger, DM
Koopmans, PP
Sprengers, HG
Juttmann, JR
Richter, C
Meenhorst, PL
Hoetelmans, RMW
Kroon, FP
Bravenboer, B
Hamann, D
Boucher, CAB
Borleffs, JCC
Citation: Jwtc. Stuart et al., Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study), AIDS, 13(7), 1999, pp. F53-F58
Authors:
Pakker, NG
Kroon, EDMB
Roos, MTL
Otto, SA
Hall, D
Wit, FWNM
Hamann, D
van der Ende, ME
Claessen, FAP
Kauffmann, RH
Koopmans, PP
Kroon, FP
ten Napel, CHH
Sprenger, HG
Weigel, HM
Montaner, JSG
Lange, JMA
Reiss, P
Schellekens, PTA
Miedema, F
Citation: Ng. Pakker et al., Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy, AIDS, 13(2), 1999, pp. 203-212
Authors:
Kroon, FP
Beersma, MFC
Kroes, ACM
Groeneveld, PHP
van Dissel, JT
Citation: Fp. Kroon et al., Vaccination and HIV-1 replication during highly active antiretroviral therapy, AIDS, 13(1), 1999, pp. 135-136
Authors:
Kroon, FP
van Dissel, JT
Ravensbergen, E
Nibbering, PH
van Furth, R
Citation: Fp. Kroon et al., Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations, VACCINE, 18(5-6), 1999, pp. 524-530
Authors:
Kroon, FP
van Dissel, JT
Ravensbergen, E
Nibbering, PH
van Furth, R
Citation: Fp. Kroon et al., Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi (R)), VACCINE, 17(23-24), 1999, pp. 2941-2945
Authors:
Geertsma, MF
van Wengen-Stevenhagen, A
van Dam, EM
Risberg, K
Kroon, FP
Groeneveld, PHP
Nibbering, PH
Citation: Mf. Geertsma et al., Decreased expression of zeta molecules by T lymphocytes is correlated withdisease progression in human immunodeficiency virus-infected persons, J INFEC DIS, 180(3), 1999, pp. 649-658
Risultati:
1-11
|